At Troponix, we deliver cutting-edge, AI-driven cardiac diagnostic services designed to detect, predict, and prevent heart disease with unprecedented accuracy. Our solutions bridge the gap between hospital-grade diagnostics and wearable convenience, empowering healthcare providers and patients with real-time, actionable insights.
Our Core Services
1. U-Tropia Wearable Cardiac Monitoring
Continuous, Lab-Accurate Troponin & ECG Tracking
- 24/7 Biomarker Surveillance – Detect rising troponin levels and arrhythmias before symptoms escalate
- AI-Powered Risk Stratification – Instant alerts for ACS, silent ischemia, and heart failure decompensation
- Multi-Modal Data Integration – Combines ECG, troponin trends, and patient history for comprehensive assessment
Use Cases:
- Emergency department triage
- Post-PCI monitoring
- Chronic heart disease management
2. Telecardiology & Remote Patient Monitoring (RPM)
Seamless Integration with Healthcare Systems
- Cloud-Based Dashboard – Real-time data access for care teams
- Automated Physician Alerts – Critical findings routed via HIPAA-compliant messaging
- Virtual Consultations – Cardiologist-overread services for rural/underserved areas
Key Features:
- EHR integration (Epic, Cerner, HL7/FHIR)
- Reimbursement-compliant RPM (CPT 99453/99454)
- Population health analytics
3. Hospital & Health System Partnerships
Turnkey Implementation for Smart Cardiac Care
- ED Accelerator Program – Reduce door-to-balloon time by 40%
- Inpatient Monitoring Suite – Replace telemetry with wireless wearables
- Readmission Prevention – 30-day post-discharge monitoring bundles
ROI Delivered:
- $8,200 savings per ACS case
- 29% reduction in unnecessary admissions
4. Clinical Research & Trial Support
Next-Gen Cardiac Biomarker Studies
- Decentralized Trial Capabilities – Continuous troponin data collection
- Regulatory-Grade Analytics – FDA 21 CFR Part 11 compliant
- Custom Biosensor Development – Tailored biomarker panels
Why Choose Troponix?
✔ Lab Precision in a Wearable – CLIA-waived troponin detection
✔ Faster Time-to-Treatment – Median 3.1-hour diagnosis acceleration
✔ Proven Cost Reduction – 58% lower monitoring costs vs. traditional care
✔ End-to-End Support – Implementation, training, and QA programs